Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Shares up 10 Percent on Lung Cancer Biomarker Data

NEW YORK, April 19 (GenomeWeb News) - Shares in Sequenom were trading up 10.3 percent, or $.10, at $1.11 in early afternoon trading on news that the company has developed a process to identify epigenetic markers in lung cancer.


The process performs high-throughput DNA methylation analysis based on Sequenom's MassArray system, the company said in a statement.


As described in a late-breaking poster at the American Association for Cancer Research meeting in Anaheim, Calif., Sequenom in collaboration with University of Liverpool researchers evaluated the performance of the procedure in a clinical setting by analyzing the cytosine methylation pattern in non-small cell lung cancer.


Shares of Sequenom reached a morning high of $1.20 immediately following the news, but have since dipped to their current level.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.